Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3545062 (GS-5816, Velpatasvir) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Nonstructural protein 5A in Hepatitis C virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3307224] [UniProtKB: Q5L478] | ||||||||
ChEMBL | Inhibition of NS5A Y93H mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 8.07 | pEC50 | 8.5 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Y93H mutant in HCV genotype 3a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 8.49 | pEC50 | 3.2 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Q30E mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 9.6 | pEC50 | 0.25 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A L31M mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 9.66 | pEC50 | 0.22 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A A30K mutant in HCV genotype 3a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 9.68 | pEC50 | 0.21 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in HCV genotype 6e D88 infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 9.89 | pEC50 | 0.13 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A M28T mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 9.98 | pEC50 | 0.1 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in HCV genotype 5a SA13 infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.27 | pEC50 | 0.05 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Y93C mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.28 | pEC50 | 0.05 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Q30H mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.49 | pEC50 | 0.03 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Q30R mutant in HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.51 | pEC50 | 0.03 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in HCV genotype 1b Con1 infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.8 | pEC50 | 0.02 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A L31M mutant in HCV genotype 2a J6 (M31) infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.8 | pEC50 | 0.02 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in wild type HCV genotype 1b infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.8 | pEC50 | 0.02 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in HCV genotype 2a J6 infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.8 | pEC50 | 0.02 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in HCV genotype 1a H77 infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.85 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in wild type HCV genotype 1a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.85 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A in wild type HCV genotype 3a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.89 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A R44K mutant in HCV genotype 2b infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.96 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A Y93H mutant in HCV genotype 1b infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 10.96 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A P58S mutant in HCV genotype 2b infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 11 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL | Inhibition of NS5A N62V mutant in HCV genotype 2a infected in human HuH7 replicon cells assessed as reduction in viral replication after 3 days by luciferase reporter gene assay | B | 11 | pEC50 | 0.01 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 2415-2427 [PMID:31230974] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]